NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravis Aarhus, Denmark, 10 March 2026 – NMD Pharma A/S, a ...
Ethio Telecom, Djibouti Telecom, and Sudatel Group sign strategic fiber agreement The cross-border fiber project aims to create a resilient terrestrial fiber corridor 05 Feb 2026 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果